Radiotherapy and Immunotherapy Combinations in Non-small Cell Lung Cancer: A Promising Future?

被引：8
|
作者：
Hanna, G. G. [1 ]
Illidge, T. [2 ]
机构：
[1] Queens Univ Belfast, Ctr Canc Res & Cell Biol, 95 Lisburn Rd, Belfast BT9 7AE, Antrim, North Ireland
[2] Univ Manchester, Manchester Acad Hlth Sci Ctr, Inst Canc Sci, Manchester Canc Res Ctr,Christie Hosp, Manchester, Lancs, England
来源：
CLINICAL ONCOLOGY | 2016年 / 28卷 / 11期
关键词：
Checkpoint inhibition; immunotherapy; NSCLC; radiotherapy; IMMUNE-RELATED RESPONSE; TUMOR MICROENVIRONMENT; IONIZING-RADIATION; SOLID TUMORS; MELANOMA; MODULATION; MECHANISMS; IPILIMUMAB; RESISTANCE; DOCETAXEL;
D O I：
10.1016/j.clon.2016.07.014
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The goal of re-programming the host immune system to target malignancy with durable anti-tumour clinical responses has been speculated for decades. In the last decade such speculation has been transformed into reality with unprecedented and durable responses to immune checkpoint inhibitors seen in solid tumours. This mini-review considers the mechanism of action of immune modulating agents and the potential for combination with radiotherapy in the treatment of non-small cell lung cancer. (C) 2016 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码：726 / 731
页数：6
相关论文
共 50 条
  • [21] Current and future biomarkers for outcomes with immunotherapy in non-small cell lung cancer
    Duchemann, Boris
    Remon, Jordi
    Naigeon, Marie
    Cassard, Lydie
    Jouniaux, Jean Mehdi
    Boselli, Lisa
    Grivel, Jonathan
    Auclin, Edouard
    Desnoyer, Aude
    Besse, Benjamin
    Chaput, Nathalie
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (06) : 2937 - 2954
  • [22] Immunotherapy in non-small cell lung cancer: Past, present, and future directions
    Punekar, Salman R. R.
    Shum, Elaine
    Grello, Cassandra Mia
    Lau, Sally C. C.
    Velcheti, Vamsidhar
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [23] Promising outcome of stereotactic body radiotherapy for treatment of non-small cell lung cancer
    Guckenberger, M.
    Wuff, J.
    Mueller, G.
    Krieger, T.
    Gabor, M.
    Flentje, M.
    ONKOLOGIE, 2008, 31 : 129 - 129
  • [24] Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer: Past, Present, and Future
    McCall, Neal S.
    Higgins, Kristin A.
    ONCOLOGY-NEW YORK, 2021, 35 (06): : 311 - 319
  • [25] Combining immunotherapy and radiotherapy in lung cancer: a promising future?
    Zhou, Jieling
    Huang, Qian
    Huang, Zijian
    Li, Jiqiang
    JOURNAL OF THORACIC DISEASE, 2020, 12 (08) : 4498 - 4503
  • [26] Is the Combination of Immunotherapy and Radiotherapy in Non-small Cell Lung Cancer a Feasible and Effective Approach?
    Spaas, Mathieu
    Lievens, Yolande
    FRONTIERS IN MEDICINE, 2019, 6
  • [27] Immunotherapy combinations and chemotherapy sparing schemes in first line non-small cell lung cancer
    Sereno, Maria
    Higuera, Oliver
    Cruz Castellanos, Patricia
    Falagan, Sandra
    Mielgo-Rubio, Xabier
    Trujillo-Reyes, Juan Carlos
    Counago, Felipe
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2021, 12 (12): : 1182 - 1192
  • [28] Biomarkers of immunotherapy for non-small cell lung cancer
    Shirasawa, Masayuki
    Yoshida, Tatsuya
    Ohe, Yuichiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (01) : 13 - 22
  • [29] Perioperative Immunotherapy in Non-Small Cell Lung Cancer
    Jenny O’Brien
    J. Nicholas Bodor
    Current Treatment Options in Oncology, 2023, 24 : 1790 - 1801
  • [30] Principles of Immunotherapy in Non-Small Cell Lung Cancer
    Hsu, Melinda L.
    Naidoo, Jarushka
    THORACIC SURGERY CLINICS, 2020, 30 (02) : 187 - +
12345